Home
October 2009 November 2009 December 2009
Su Mo Tu We Th Fr Sa
Week 45 1 2 3 4 5 6 7
Week 46 8 9 10 11 12 13 14
Week 47 15 16 17 18 19 20 21
Week 48 22 23 24 25 26 27 28
Week 49 29 30
Reach urologists

Sodium Bicarbonate Infusion Found to Reduce Risk of Contrast-Induced Nephropathy Show Comments PDF Print E-mail
  
Tuesday, 08 June 2004
BERKELEY, CA (UroToday Inc.) - Contrast-induced nephropathy remains a common complication of radiographic procedures.

BERKELEY, CA (UroToday Inc.) - Contrast-induced nephropathy remains a common complication of radiographic procedures. Acute renal failure from ischemia and contrast are postulated to occur from free-radical injury. Radiocontrast nephropathy is a common cause of hospital-acquired acute renal failure and has been associated with increased in-hospital mortality and length of stay. Many protocols to prevent contrast-induced nephropathy include an infusion of sodium chloride. No studies have evaluated the efficacy of sodium bicarbonate for prophylaxis against contrast-induced renal failure. It alkalinizes the urine and reduces free-radical formation,.

A randomized controlled trial was performed to examine the efficacy of sodium bicarbonate compared to sodium chloride for preventive hydration before and after radiographic contrast. The study, performed at the Carolinas Medical Center, was reported by G. J. Merten, et al. and published in the May 19, 2004 issue of JAMA.

One-hundred and nineteen patients with a creatinine of at least 1.1 mg/dL were randomized to receive either an infusion of sodium chloride (NaCl) or sodium bicarbonate (NaHCO3) before (a bolus of 3mL/kg over 1 hour) and after (an infusion of 1 mL/kg/hr for 6 hours) the procedure. Serum creatinine levels were measured at baseline and 1 and 2 days after contrast. The primary endpoint was contrast induced nephropathy, defined as an increase in serum creatinine of 25% or more within 2 days of contrast injection.

The mean patient age was 68 years old and the most frequent radiographic procedure was cardiac catherization. Mean baseline creatinine values were 1.71 mg/dL for the NaCl group and 1.89 mg/dL for the NaHCO3 group. The primary end point of contrast induced nephropathy occurred in 8 patients (13.6%) infused with sodium chloride but only 1 (1.7%) of those receiving sodium bicarbonate (mean difference, 11.9%, P=.02). A follow-up registry of 191 consecutive patients receiving prophylactic NaHCO3 resulted in only 3 cases of contrast-induced nephropathy (1.6%).

Additional data analysis revealed that patients receiving sodium bicarbonate achieved urine pH's of 6.5 as opposed to 5.6 with those receiving sodium chloride. This alkalinization is theorized to have a protective effect against the formation of free-radicals that may cause nephropathy.

An editorial, provided by G. M. Chertow from University of California San Francisco, discussed the limitations of prior studies that attempted to evaluate other techniques to reduce contrast induced nephropathy. These included N-acetylcysteine administration and hemofiltration. These techniques for prevention required complex interventions (dialysis for hemofiltration) or a delay in the performance of the study (1-2 days for oral administration of N-acetylcysteine). The efforts of the Carolina group were applauded for the power of their study and completion of the trial even though it appeared to be a strongly positive study during initial data collection. The authors and the editorial both concluded that a brief infusion of isotonic sodium bicarbonate pre- and post-exposure to contrast should now be considered the treatment of choice for prevention of radiocontrast nephropathy.

JAMA 2004;291:2328-34, 2376-77

Written by Michael J. Metro, MD, a Contributing Editor with UroToday.

Reader Comments

Please log-in or register in order to submit comments.

Powered by AkoComment!

 
User Rating: / 6
PoorBest


 
Visitor Ratings:
Healthcare Professionals:
5 (1 votes)

Patients:
5 (3 votes)

No Affiliation:
5 (2 votes)


Bookmark and Share

Member's Section

Login

Sign Up

Quick Search

Meet the Expert


All Experts


Featured Conference

Media and Publisher

Advertising Rates
Reprints

Working with Industry

Case Studies
Sponsorship Opportunities

Renal Cancer
Sponsored By